Commitment to the CD4 lineage mediated by extracellular signal-related kinase mitogen-activated protein kinase and lck signaling

Autor: L L, Sharp, S M, Hedrick

Publikováno v: Journal of immunology (Baltimore, Md. : 1950). 163(12)

The development of T cells results in a concordance between the specificity of the TCR for MHC class I and class II molecules and the expression of CD8 and CD4 coreceptors. Based on analogy to simple metazoan models of organ development and lineage c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7d6795b6798b94ed45f7cb713d613f7c
https://pubmed.ncbi.nlm.nih.gov/10586054

Clean Energy From Waste and Coal

Autor: M. RASHID KHAN, Kenneth E. Daugherty, Charles R. McGowin, Evan E. Hughes, M. D. Ackerson, E. C. Clausen, J. L. Gaddy, L. G. Softley, J. D. Broder, R. C. Strickland, M. J. Beck, J. W. Barrier, A. Goyal, A. Rehmat, Meyer Steinberg, Joseph T. Hamrick, L. A. Edye, G. N. Richards, G. Zheng, D. J. Stopek, A. L. Justice, P. Assawaweroonhakarn, J. L. Kuester, L. L. Sharp, R. O. Ness, Matthew A. McMahon, S. J. DeCanio, James R. Donnelly, C. C. Lee, G. L. Huffman, Bassam S. Attili, Kevin D. Ingram, Chia-Hui Tai, Mohit Uberoi, Farhang Shadman, Russell Hill, Baushu Zhao, Matthew Poslusny, Paul Moore, Carl A. Holley, Vas Choudhry, Steven R. Hadley, James T. Cobb, C. P. Mangelsdorf, Jean R. Blachere, Kunal Banerjee, Daniel Reed, Clayton Crouch, Coby Miller, Jingqi Li, Jeanette Trauth, H. M. Kosstrin, B. E. Levie

ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer.

Autor: Carrera PM; German Cancer Research Center, Heidelberg, Germany; Healtempact: Health/Economic Insights-Impact, Hengelo, The Netherlands. Electronic address: pricivel.carrera@gmail.com., Curigliano G; European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan., Santini D; Oncologia Medica A, Policlinico Umberto 1, La Sapienza Università di Roma, Rome, Italy., Sharp L; Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK., Chan RJ; Caring Futures Institute, Flinders University, Adelaide, Australia., Pisu M; University of Alabama in Birmingham, Birmingham, USA., Perrone F; National Cancer Institute IRCCS G. Pascale Foundation, Naples, Italy., Karjalainen S; Tampere University, Tampere, Finland., Numico G; Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy., Cherny N; Shaare Zedek Medical Center, Jerusalem, Israel., Winkler E; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg University, Medical Faculty, Department of Medical Oncology, Heidelberg, Germany., Amador ML; Spanish Association Against Cancer (AECC), Madrid, Spain., Fitch M; Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada., Lawler M; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Meunier F; European Initiative on Ending Discrimination against Cancer Survivors and Belgian Royal Academy of Medicine (ARMB), Brussels, Belgium., Khera N; Mayo Clinic, Phoenix, USA., Pentheroudakis G; European Society for Medical Oncology, Lugano, Switzerland., Trapani D; European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan., Ripamonti CI; University of Brescia, Brescia, Italy.

Publikováno v: ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 102992. Date of Electronic Publication: 2024 Apr 15.

Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study.

Autor: Rosato V; Unit of Medical Statistics and Biometry, National Cancer Institute, IRCCS Foundation, Milan, Italy., Gómez-Rubio P; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; CIBERONC, Spain., Molina-Montes E; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; CIBERONC, Spain., Márquez M; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; CIBERONC, Spain., Löhr M; Gastrocentrum, Karolinska Institutet and University Hospital, Stockholm, Sweden., O'Rorke M; Centre for Public Health, Belfast, Queen's University Belfast, Belfast, UK., Michalski CW; Department of Surgery, Technical University of Munich, Munich.; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Molero X; Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Universitat Autònoma de Barcelona, Barcelona.; CIBEREHD., Farré A; Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona., Perea J; Department of Surgery, University Hospital 12 de Octubre.; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Kleeff J; Department of Surgery, Technical University of Munich, Munich.; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Crnogorac-Jurcevic T; Barts Cancer Institute, Centre for Molecular Oncology, Queen Mary University of London, John Vane Science Centre, London., Greenhalf W; Department of Molecular and Clinical Cancer Medicine, The Royal Liverpool University Hospital, Liverpool, UK., Ilzarbe L; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; Hospital del Mar-Parc de Salut Mar, Barcelona., Tardón A; Department of Medicine, Instituto Universitario de Oncología del Principado de Asturias, Oviedo.; CIBERESP, Spain., Gress T; Department of Gastroenterology, University Hospital of Giessen and Marburg, Marburg, Germany., Barberá VM; Molecular Genetics Laboratory, General University Hospital of Elche., Domínguez-Muñoz E; Department of Gastroenterology, University Clinical Hospital of Santiago de Compostela., Muñoz-Bellvís L; General and Digestive Surgery Department, Salamanca University Hospital, Elche, Santiago de Compostela, and Salamanca, Spain., Balsells J; Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Universitat Autònoma de Barcelona, Barcelona.; CIBEREHD., Costello E; Department of Molecular and Clinical Cancer Medicine, The Royal Liverpool University Hospital, Liverpool, UK., Iglesias M; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; Hospital del Mar-Parc de Salut Mar, Barcelona., Kong B; Department of Surgery, Technical University of Munich, Munich., Mora J; Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona., O'Driscoll D; National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland., Poves I; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; Hospital del Mar-Parc de Salut Mar, Barcelona., Scarpa A; ARC-Net centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital trust of Verona, Verona, Italy., Ye W; Gastrocentrum, Karolinska Institutet and University Hospital, Stockholm, Sweden., Hidalgo M; Madrid-Norte-Sanchinarro Hospital, Madrid, Spain., Sharp L; National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland.; Newcastle University, Institute of Health & Society, Newcastle, UK., Carrato A; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; Department of Oncology, Ramón y Cajal University Hospital, IRYCIS, Alcala University., Real FX; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; Epithelial Carcinogenesis Group.; Spanish National Cancer Research Centre (CNIO), Madrid.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain., La Vecchia C; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid.; CIBERONC, Spain.

Publikováno v: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) [Eur J Cancer Prev] 2021 Nov 01; Vol. 30 (6), pp. 423-430.

Barriers and facilitators to discussing HPV with head and neck cancer patients: A qualitative study using the theoretical domains framework.

Autor: O'Connor M; National Cancer Registry Ireland, Kinsale Road, Cork, Ireland., Waller J; Department of Behavioural Science and Health, University College London, London, UK., Gallagher P; School of Psychology, Dublin City University, Dublin, Ireland., O'Donovan B; National Cancer Registry Ireland, Kinsale Road, Cork, Ireland. Electronic address: BEODONOV@tcd.ie., Clarke N; School of Psychology, Dublin City University, Dublin, Ireland., Keogh I; College of Medicine Nursing & Health Sciences, National University of Ireland Galway, Ireland., MacCarthy D; Division of Restorative Dentistry and Periodontology, Dublin Dental University Hospital, Dublin, Ireland., O'Sullivan E; Cork University Dental School and Hospital, Cork, Ireland., Timon C; St. James's Hospital, James's Street, Dublin, Ireland., Martin C; Department of Histopathology, University of Dublin, Trinity College, Ireland; Department of Pathology, Coombe Women and Infants University Hospital, Ireland., O'Leary J; Department of Histopathology, University of Dublin, Trinity College, Ireland; Department of Pathology, Coombe Women and Infants University Hospital, Ireland., Sharp L; Institute of Health & Society, Newcastle University, UK.

Publikováno v: Patient education and counseling [Patient Educ Couns] 2020 May 30. Date of Electronic Publication: 2020 May 30.